Product Description
| Cat Number | T3673 |
|---|---|
| Category | Biochemical |
| Pack Size | 1EA |
| Description | Mollugin (Rubimaillin) may be a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway. Mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF- κ B. Mollugin may be a novel therapeutic candidate for bone loss-associated disorders including osteoporosis, rheumatoid arthritis, and periodontitis. Also, it has anticancer efficacy, can modulate the HER2 pathway in HER2-overexpressing Y cells with a potential role in the treatment and prevention of human breast and ovarian Y with HER2 overexpression. |
| Molecular Weight | 284.31 |
| Purity | 0.98 |
| Formula | C17H16O4 |
| Smiles | COC(=O)c1c(O)c2ccccc2c2OC(C)(C)C=Cc12 |
| Storage | -20 ℃ |
| View Document | |
| Note | This product is for Research Use Only |
Share Item: